Immune‐related adverse events with mogamulizumab in cutaneous T‐cell lymphoma: A multicentre study
In a nationwide multicentre study of 403 patients with cutaneous T‐cell lymphoma treated with mogamulizumab, non‐MAR immune‐related adverse events were reported in 8.4% of patients across responding centres. These events were diverse, sometimes severe or persistent, and could occur late during mogamulizumab treatment.
David Neubauer +28 more
wiley +1 more source
Neutrophils: Heterogeneity, Biology, Diseases, and Therapeutic Strategies
Neutrophils exhibit remarkable functional plasticity and play dual roles in tissue protection and disease progression. This review summarizes their key biological functions and highlights the shift from conventional broad‐spectrum interventions to neutrophil‐based drug delivery systems.
Yibing Zhang +4 more
wiley +1 more source
Correlation of anti-GP2 IgA with celiac disease (CD) specific antibodies.
Association of anti-GP2 IgA with endomysial antibodies (EmA) (A) and anti- tissue transglutaminase (tTG) IgA (B) in 174 patients with active CD.
Ursula Range (750430) +5 more
core +1 more source
Genetic predisposition to celiac disease in persons with Down syndrome in Northwestern Mexico
Introduction and aim: Celiac disease (CD) is an autoimmune enteropathy triggered by ingested gluten, with intra- and extra-gastrointestinal symptoms. Individuals with Down syndrome (DS) have a higher prevalence of autoimmune disorders, including CD. This
C. Ávalos-Camacho +9 more
doaj +1 more source
Serum anti-tissue transglutaminase IgA antibodies in patients with psoriasis vulgaris and relation to its severity [PDF]
Background: Psoriasis is a common skin disease associated with different co-morbidities. High serum levels of anti-tissue transglutaminase-2 IgA (TTG-IgA), produced and deposited in the intestine, characterizes celiac disease.
Sawsan el Zayat +3 more
doaj +1 more source
Potential celiac disease is characterized by positive results from serologic tests for tissue transglutaminase antibodies (anti-TG2) but normal duodenal architecture (Marsh stages 0-1). There is controversy over the best way to manage these patients.
Cielo D. +10 more
core +1 more source
Prevalence of Tissue Transglutamase Antibodies in cases of Celiac Disease
Celiac disease is a human leukocyte antigen-DQ2 (or DQ8) associated autoimmune disorder of the small intestine induced by dietary exposure to wheat gliadin, barley hordein, rye secalin and possibly oat avenis. It is characterized by mucosal damage, loss
Samreen Soomro +3 more
doaj +4 more sources
Background: Endomysial antibodies have recently been shown to react with tissue transglutaminase. This study was undertaken to investigate whether the tissue distribution of transglutaminase is also compatible with reticulin, jejunal, and fibroblast ...
Sulkanen +17 more
core +2 more sources
Clinical updates on diagnosing glutensensitive enteropathy
In the last twenty years serology for the diagnosis of coeliac disease has improved substantially. As the result of our serological studies in 1998 we proposed a gentle, low-risk, and cost effective algorithm for diagnosing various forms of gluten ...
Faruk Hadziselimovic +1 more
doaj
Anti-tissue transglutaminase antibodies (TG2A) positivity and the risk of vitamin D deficiency among children - a cross-sectional study in the generation R cohort. [PDF]
van der Velde LA +5 more
europepmc +1 more source

